Antiplatelet agents for chronic kidney disease - Wikidata - awgldk - TriplyDB

Antiplatelet agents for chronic kidney disease

Antiplatelet agents for chronic kidney disease

http://www.wikidata.org/entity/Q24200752

about

Current tools for prediction of arteriovenous fistula outcomes Anticoagulation in chronic kidney disease patients-the practical aspects.ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II - Management of Various Cardiovascular Complications.Comprehensive Care for People With Diabetic Kidney Disease Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease Risk of Stroke in Patients with ESRD Modulation of stroke risk in chronic kidney disease.Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.Hemodialysis Tunneled Catheter Noninfectious Complications.PCI or CABG, That is the Question!The effect of aspirin on kidney allograft outcomes; a short review to current studies.Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study.Not All Deaths in CKD Are from a Broken Heart.Primary Prevention of Stroke in Chronic Kidney Disease Patients: A Scientific Update.Premature Coronary Artery Disease and Early Stage Chronic Kidney Disease.Hemostatic Abnormalities in Severe Renal Failure: Do They Bark or Bite?Syncope and Collapse Are Associated with an Increased Risk of Cardiovascular Disease and Mortality in Patients Undergoing Dialysis

P2860

Q27010042-F5F634B1-9711-486F-8FC8-90A807D8AFFA Q35232128-56F735A0-EBCD-4254-8663-6DD1207B9340 Q35904403-902AFFB3-8AAB-40C5-A40A-649D7BDD9C80 Q35953885-24C21087-2174-4286-99FA-363BBC61618F Q36021782-1677705B-A288-467E-9F12-86B27740CA08 Q36025660-421E64AD-F869-4DC6-BE39-122CA946B495 Q36482963-3B1EBBE3-9263-4B4A-8855-250DC9C57696 Q37463969-B94960CE-6BAE-4795-A348-712139F49FC8 Q37674559-E0E2A4EC-918B-4642-AE18-177FBDED4CB1 Q42345017-BABC12A2-826C-431A-B162-3FD182194510 Q42361916-E9CD9698-CD5E-4C19-B47A-B8FC70530E34 Q42385835-0EB0F89C-FC15-4C44-A0B5-E1F1A7763C85 Q43236768-160D425A-89E2-4ECC-AD1E-9D1E1A6AACF1 Q47188294-5D860D89-3AC3-423E-850D-A70E0D22D55E Q50099911-B8D51E50-42D2-4DA9-B4DA-EF116531A803 Q55186500-97320D28-E53A-4B17-8793-1097AB7334CA Q58702466-5CCF6173-4F7D-409A-856E-F727BD4AE8B7

P2860

Antiplatelet agents for chronic kidney disease

http://www.wikidata.org/entity/Q24200752

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Antiplatelet agents for chronic kidney disease

@en

Antiplatelet agents for chronic kidney disease

@en-gb

Antiplatelet agents for chronic kidney disease

@nl

type

label

Antiplatelet agents for chronic kidney disease

@en

Antiplatelet agents for chronic kidney disease

@en-gb

Antiplatelet agents for chronic kidney disease

@nl

prefLabel

Antiplatelet agents for chronic kidney disease

@en

Antiplatelet agents for chronic kidney disease

@en-gb

Antiplatelet agents for chronic kidney disease

@nl

P1433

Q24200752-5DD44D5B-877E-4D55-B9ED-9B26B819AC12

P1476

Q24200752-EA0B0A48-7141-41C4-90EA-C8B17A205F2B

P2093

Q24200752-421694AC-0061-4BA9-94AE-5F47AD894FFC

Q24200752-6AA90D09-DE84-49CD-B358-709388DED673

Q24200752-81DE6E3D-892A-4C80-A1B2-9297A6B78363

Q24200752-88FA81A2-7F96-4FF4-B5DC-40BB30EBC772

Q24200752-E50787E2-F1A5-4358-A3DA-59478C462325

Q24200752-F4760A9B-4974-41C4-902A-A5F6BE5264CE

P2860

Q24200752-026CEC1E-12FA-4D72-A25E-AEADCA059015

Q24200752-0421F52C-AA27-43BF-8DB9-C0DFDF706715

Q24200752-06432650-3D02-4D7A-8359-7475FFC1F4A2

Q24200752-0679D24B-1CEA-4E50-A4C2-278D70A80E19

Q24200752-0A3BFC8D-9F5A-4B78-B957-6B0B146D4A8E

Q24200752-0F4DBDB0-A678-4794-98E8-CCAC0595AE13

Q24200752-106F6301-C85B-4A6B-970B-03AB7A092DFF

Q24200752-14D14227-7B0C-4001-A9A3-4E38F91113C0

Q24200752-1543CC56-935D-4442-AA55-EBE739CFCC0F

Q24200752-1695625E-EA18-4B1A-8761-3071C2404A1C

P31

Q24200752-CF9F7659-CAA3-4CAD-AFED-78D9B2511240

Q24200752-e0697210-1601-43e7-99b3-c457b3ea061a

P356

Q24200752-3D5CBD57-94F1-4487-9948-E4B40F9D3CB3

P50

Q24200752-10F1F966-6B73-4D49-BF0C-4BEABAECE8AC

Q24200752-4AF53910-7E68-43D2-8741-4319B48F6629

Q24200752-9F25991C-4E39-46FB-B43A-E241C10A9B3B

Q24200752-CB649E79-DA06-425F-B0B6-6E5B66277980

P577

Q24200752-D6CF471E-13B6-4919-A696-3825B0B4AC26

P698

Q24200752-901B9F70-2E63-4C97-B5AA-8F3CB44CED5C

P356

14651858.CD008834.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Antiplatelet agents for chronic kidney disease

@en

P2093

Angela C Webster

http://www.w3.org/2001/XMLSchema#string

Fabio Pellegrini

http://www.w3.org/2001/XMLSchema#string

Giovanni FM Strippoli

http://www.w3.org/2001/XMLSchema#string

Lucia Di Micco

http://www.w3.org/2001/XMLSchema#string

Meg J Jardine

http://www.w3.org/2001/XMLSchema#string

Mona Razavian

http://www.w3.org/2001/XMLSchema#string

P2860

Antiplatelet agents for chronic kidney disease

Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Measuring inconsistency in meta-analyses

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy

Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease

Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial

P31

scholarly article

P356

10.1002/14651858.CD008834.PUB2

http://www.w3.org/2001/XMLSchema#string

P50

Suetonia Cressida Palmer

Jonathan C. Craig

P577

2013-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23450589

http://www.w3.org/2001/XMLSchema#string